Condition
Oligodendroglioma, Anaplastic
Total Trials
2
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Radiation Therapy
Research Leaders
19 sponsors active, led by University Hospital, Umeå
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Radiation Therapy1
Active Sponsors
- University Hospital, Umeå1
- Ryhov County Hospital1
- St. Olavs Hospital1
- Medical Center Haaglanden1
- Uppsala University Hospital1
Top Investigators
Head of Neurooncology
Related Conditions
- Oligodendroglioma2
- Astrocytoma Grade Ii1
- Diffuse Astrocytoma Idhmutant1
- Astrocytoma Grade Iii1